|
BAC |
Annual MD&A for the year ended December 31, 2023 |
MD & A (Discussion et analyse de la direction) |
26/04/2024 |
 Open Filing (391.54 Ko) |
|
BAC |
Annual Audited Financial Statements for the year ended December 31, 2023 |
États financiers annuels vérifiés |
26/04/2024 |
Open Filing (1.02 Mo) |
|
HERC |
Form 9 - Proposed Notice of issuance of Securities - (Amended Crescita) |
Émission proposée des titres cotés |
26/04/2024 |
Open Filing (198.91 Ko) |
|
HERC |
Hercules Resources Corp Provides Update on CAD$5-Million Equity Capital Facility with Crescita Capital LLC |
Communiqué de presse |
26/04/2024 |
Open Filing (113.47 Ko) |
|
TOC |
Tocvan Closes First Tranche of Private Placement for $2.1 Million |
Communiqué de presse |
26/04/2024 |
Open Filing (231.64 Ko) |
|
ETI |
Annual Summary 2023 |
Annual Summary |
25/04/2024 |
Open Filing (966.64 Ko) |
|
ETI |
Management Discussion & Analysis - YE 2023 |
MD & A (Discussion et analyse de la direction) |
25/04/2024 |
Open Filing (199.24 Ko) |
|
ETI |
Audited Consolidated Financial Statements - YE 2023 |
États financiers annuels vérifiés |
25/04/2024 |
Open Filing (1.57 Mo) |
|
ABND |
Form 5 - Quarterly Listing Statement |
Déclaration d'inscription trimestrielle |
25/04/2024 |
Open Filing (240.96 Ko) |
|
TMAS |
Annual MD&A |
MD & A (Discussion et analyse de la direction) |
25/04/2024 |
Open Filing (308.46 Ko) |
